Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma

被引：0

作者：

Sakai, Chio ^{[1
]}

Matsuyama, Masashi ^{[1
]}

Nakajima, Masayuki ^{[1
]}

Matsumura, Sosuke ^{[1
]}

Nonaka, Mizu ^{[1
]}

Arai, Naoki ^{[1
]}

Kuramoto, Kenya ^{[1
]}

Yoshida, Kazufumi ^{[1
]}

Morishima, Yuko ^{[1
]}

Muratani, Masafumi ^{[2
]}

Hizawa, Nobuyuki ^{[1
]}

机构：

[1] Univ Tsukuba, Fac Med, Dept Pulm Med, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan

[2] Univ Tsukuba, Fac Med, Dept Genome Biol, Ibaraki, Japan

来源：

ALLERGOLOGY INTERNATIONAL | 2024年 / 73卷 / 03期

关键词：

D O I：

10.1016/j.alit.2024.03.005

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：473 / 476

页数：4

共 50 条

[21] Effect Of Mepolizumab In Severe Eosinophilic Asthma Patients Eligible For Omalizumab Treatment
Albers, F. C.
Price, R.
Yancey, S.
Bradford, E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[22] Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
Magnan, A.
Bourdin, A.
Prazma, C. M.
Albers, F. C.
Price, R. G.
Yancey, S. W.
Ortega, H.
ALLERGY, 2016, 71 (09) : 1335 - 1344
[23] Mepolizumab for severe eosinophilic asthma
Robinson, Douglas S.
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (01) : 13 - 17
[24] Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
Howarth, Peter
Quirce, Santiago
Papi, Alberto
Israel, Elliot
Mallett, Stephen
Bates, Stewart
Yancey, Steve
Albers, Frank C.
Kwon, Namhee
ALLERGY, 2020, 75 (08) : 2085 - +
[25] Asthma Control In Patients With Severe Eosinophilic Asthma Treated With Mepolizumab
Llanos-Ackert, J. -P.
Price, R. G.
Forshag, M.
Yancey, S.
Liu, M. C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[26] Treatment Response Of Mepolizumab On Health Status And Asthma Control In Patients With Severe Eosinophilic Asthma
Chupp, G.
Albers, F. C.
Nelsen, L. M.
Bratton, D. J.
Wang-Jairaj, J.
Bradford, E.
Jones, P. W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[27] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
Harvey, E.
Langton, D.
Powell, H.
Gibson, P.
RESPIROLOGY, 2019, 24 : 42 - 42
[28] Clinical response to mepolizumab in patients with severe eosinophilic asthma
Harvey, Erin
Langton, David L.
Powell, Heather
Gibson, Peter G.
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[29] Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
Crimi, Claudia
Campisi, Raffaele
Cacopardo, Giulia
Doria, Giacomo
Intravaia, Rossella
Morena, Porto
Sabrina, Genco
Sorrentino, Ramona
Crimi, Nunzio
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[30] Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma
Nin Valencia, A. R. C.
Sanchez Ocando, H.
Caballero, M. L.
Barranco, P.
Dominguez Ortega, J.
Romero, D.
Luna, A.
Lopez Carrasco, V
Quirce, S.
ALLERGY, 2020, 75 : 397 - 397

← 1 2 3 4 5 →